PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|17|1756-1774

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.17, 2016-05, pp. : 1756-1774

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olaparib, PARP1 inhibitor in ovarian cancer

By Marchetti Claudia   Imperiale Ludovica   Gasparri Maria Luisa   Palaia Innocenza   Pignata Sandro   Boni Terenzio   Bellati Filippo   Benedetti Panici Pierluigi  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1575-1584

Informa Healthcare

Access to resources Recommend Favorite

Modulation of Transcription by PARP-1: Consequences in Carcinogenesis and Inflammation

By  

Current Medicinal Chemistry, Vol. 14, Iss. 11, 2007-05 ,pp. : 1179-1187

Bentham Science Publishers

Access to resources Recommend Favorite

Development of PARP inhibitors in oncology

By Rodon Jordi   Iniesta Maria D   Papadopoulos Kyriakos  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite

Cell Cycle Regulation in the G1 Phase: A Promising Target for the Development of New Chemotherapeutic Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 8, Iss. 12, 2001-10 ,pp. : 1487-1503

Bentham Science Publishers

Access to resources Recommend Favorite

Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 4, 2011-12 ,pp. : 326-333

Bentham Science Publishers

Access to resources Recommend Favorite